190 related articles for article (PubMed ID: 34074290)
1. Diastolic dysfunction in a pre-clinical model of diabetes is associated with changes in the cardiac non-myocyte cellular composition.
Cohen CD; De Blasio MJ; Lee MKS; Farrugia GE; Prakoso D; Krstevski C; Deo M; Donner DG; Kiriazis H; Flynn MC; Gaynor TL; Murphy AJ; Drummond GR; Pinto AR; Ritchie RH
Cardiovasc Diabetol; 2021 Jun; 20(1):116. PubMed ID: 34074290
[TBL] [Abstract][Full Text] [Related]
2. Exercise training prevents the development of cardiac dysfunction in the low-dose streptozotocin diabetic rats fed a high-fat diet.
Epp RA; Susser SE; Morissette MP; Kehler DS; Jassal DS; Duhamel TA
Can J Physiol Pharmacol; 2013 Jan; 91(1):80-9. PubMed ID: 23369057
[TBL] [Abstract][Full Text] [Related]
3. Changes in Titin and Collagen Modulate Effects of Aerobic and Resistance Exercise on Diabetic Cardiac Function.
Li S; Liang M; Gao D; Su Q; Laher I
J Cardiovasc Transl Res; 2019 Oct; 12(5):404-414. PubMed ID: 30820865
[TBL] [Abstract][Full Text] [Related]
4. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH
Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497
[TBL] [Abstract][Full Text] [Related]
5. Comparison of speckle-tracking echocardiography with invasive hemodynamics for the detection of characteristic cardiac dysfunction in type-1 and type-2 diabetic rat models.
Mátyás C; Kovács A; Németh BT; Oláh A; Braun S; Tokodi M; Barta BA; Benke K; Ruppert M; Lakatos BK; Merkely B; Radovits T
Cardiovasc Diabetol; 2018 Jan; 17(1):13. PubMed ID: 29338775
[TBL] [Abstract][Full Text] [Related]
6. Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits.
Zhang X; Zhang Z; Yang Y; Suo Y; Liu R; Qiu J; Zhao Y; Jiang N; Liu C; Tse G; Li G; Liu T
Cardiovasc Diabetol; 2018 Dec; 17(1):160. PubMed ID: 30591063
[TBL] [Abstract][Full Text] [Related]
7. Effects of Sodium-Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mice.
Croteau D; Luptak I; Chambers JM; Hobai I; Panagia M; Pimentel DR; Siwik DA; Qin F; Colucci WS
J Am Heart Assoc; 2021 Jul; 10(13):e019995. PubMed ID: 34169737
[TBL] [Abstract][Full Text] [Related]
8. Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy.
Fricovsky ES; Suarez J; Ihm SH; Scott BT; Suarez-Ramirez JA; Banerjee I; Torres-Gonzalez M; Wang H; Ellrott I; Maya-Ramos L; Villarreal F; Dillmann WH
Am J Physiol Regul Integr Comp Physiol; 2012 Oct; 303(7):R689-99. PubMed ID: 22874425
[TBL] [Abstract][Full Text] [Related]
9. Functional resilience of C57BL/6J mouse heart to dietary fat overload.
Tadinada SM; Weatherford ET; Collins GV; Bhardwaj G; Cochran J; Kutschke W; Zimmerman K; Bosko A; O'Neill BT; Weiss RM; Abel ED
Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H850-H864. PubMed ID: 34477461
[TBL] [Abstract][Full Text] [Related]
10. Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction.
Prakoso D; De Blasio MJ; Qin C; Rosli S; Kiriazis H; Qian H; Du XJ; Weeks KL; Gregorevic P; McMullen JR; Ritchie RH
Clin Sci (Lond); 2017 Jun; 131(12):1345-1360. PubMed ID: 28487469
[TBL] [Abstract][Full Text] [Related]
11. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
[TBL] [Abstract][Full Text] [Related]
12. The α11 integrin mediates fibroblast-extracellular matrix-cardiomyocyte interactions in health and disease.
Civitarese RA; Talior-Volodarsky I; Desjardins JF; Kabir G; Switzer J; Mitchell M; Kapus A; McCulloch CA; Gullberg D; Connelly KA
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H96-H106. PubMed ID: 27199132
[TBL] [Abstract][Full Text] [Related]
13. G protein-coupled receptor kinase-2: A potential biomarker for early diabetic cardiomyopathy.
Lai S; Fu X; Yang S; Zhang S; Lin Q; Zhang M; Chen H
J Diabetes; 2020 Mar; 12(3):247-258. PubMed ID: 31680450
[TBL] [Abstract][Full Text] [Related]
14. Streptozotocin-induced type II diabetic rat administered with nonobesogenic high-fat diet is highly susceptible to myocardial ischemia-reperfusion injury: An insight into the function of mitochondria.
Ansari M; Gopalakrishnan S; Kurian GA
J Cell Physiol; 2019 Apr; 234(4):4104-4114. PubMed ID: 30191974
[TBL] [Abstract][Full Text] [Related]
15. Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats.
Li G; Xing W; Zhang M; Geng F; Yang H; Zhang H; Zhang X; Li J; Dong L; Gao F
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H802-H813. PubMed ID: 29957017
[TBL] [Abstract][Full Text] [Related]
16. Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat.
Tate M; Deo M; Cao AH; Hood SG; Huynh K; Kiriazis H; Du XJ; Julius TL; Figtree GA; Dusting GJ; Kaye DM; Ritchie RH
Diab Vasc Dis Res; 2017 Sep; 14(5):423-433. PubMed ID: 28565941
[TBL] [Abstract][Full Text] [Related]
17. Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis.
Kain V; Kumar S; Sitasawad SL
Cardiovasc Diabetol; 2011 Nov; 10():97. PubMed ID: 22054019
[TBL] [Abstract][Full Text] [Related]
18. Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats.
Saito S; Teshima Y; Fukui A; Kondo H; Nishio S; Nakagawa M; Saikawa T; Takahashi N
Cardiovasc Res; 2014 Oct; 104(1):5-14. PubMed ID: 25082849
[TBL] [Abstract][Full Text] [Related]
19. Irisin inhibits high glucose-induced endothelial-to-mesenchymal transition and exerts a dose-dependent bidirectional effect on diabetic cardiomyopathy.
Liu X; Mujahid H; Rong B; Lu QH; Zhang W; Li P; Li N; Liang ES; Wang Q; Tang DQ; Li NL; Ji XP; Chen YG; Zhao YX; Zhang MX
J Cell Mol Med; 2018 Feb; 22(2):808-822. PubMed ID: 29063670
[TBL] [Abstract][Full Text] [Related]
20. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
Li CJ; Lv L; Li H; Yu DM
Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
